Endocrine Society’s Scientific Statement examines challenges of managing obesity Whether you pick low-carb, low fat or another diet plan, scientific research indicates each can help some people achieve modest long-term weight loss with potential improvement in health risks, according to the Scientific Statement the Endocrine Society issued today on managing obesity. The authors found the...
Endocrine Society analysis identifies hypoglycemia as an ongoing gap in diabetes care New research from the Endocrine Society and Avalere Health finds that clinicians lack the resources to identify, assess and manage patients who are at a high risk of developing hypoglycemia, or episodes of dangerously low blood sugar. The analysis was published in The Journal...
Diabetic microvascular disease threatens myriad complications, even as researchers continue to make progress in understanding the underlying mechanisms. According to a new scientific statement from the Endocrine Society, glycemic control remains the key. “Vascular complications are the major cause of morbidity and mortality in diabetic patients,” according to a new Endocrine Society scientific statement...
As ENDO 2018 in Chicago quickly approaches, we thought a preview of a heart-specific session would be ideal for this month’s issue, especially since it coincides with American Heart Month and Valentine’s Day. The University of Kentucky’s Lisa Tannock, MD, gives us the details about her Meet the Professor session on statin intolerance and explains...
Dulaglutide significantly improves A1C (average blood sugar concentration over two to three months) when added to ongoing treatment with a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, according to results from AWARD-10, a new Phase 3b clinical study.1 These data were published online first in The Lancet Diabetes & Endocrinology. “I’ve seen in my practice that even with...
Positive results were announced this week from the study of a new insulin pump with a predictive low glucose suspend (PLGS) feature. Data showed that the system achieved the primary outcome of reducing time spent in hypoglycemia compared to sensor-augmented pump therapy alone. The company developing the device, Tandem Diabetes Care, is marketing its new...
Doctors treating patients with type 2 diabetes should consider pulmonary function when providing care to these patients, according to a paper recently published in Endocrine Reviews. The review, by Albert Lecube, of the Universitat de Lleida, Spain, et al, points out that the lung is not usually included in the list of organs affected by...
On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1...
Diabetic microvascular disease threatens myriad complications, even as researchers continue to make progress in understanding the underlying mechanisms. According to a new scientific statement from the Endocrine Society, glycemic control remains the key. “Vascular complications are the major cause of morbidity and mortality in diabetic patients,” according to a new Endocrine Society scientific statement...
As ENDO 2018 in Chicago quickly approaches, we thought a preview of a heart-specific session would be ideal for this month’s issue, especially since it coincides with American Heart Month and Valentine’s Day. The University of Kentucky’s Lisa Tannock, MD, gives us the details about her Meet the Professor session on statin intolerance and explains...
